Wide-moat Coca-Cola delivered strong 2024 results, including increases of 12% and 7%, respectively, in organic sales and comparable EPS. Notably, global unit case volume expanded 1% for the year despite consumer pullback and geopolitical uncertainties. This resilient performance reaffirmed our investment thesis for Coke that is underpinned by its total beverage portfolio approach, steadfast commitment to product innovations and brand investments, and strong in-market execution. For 2025, we think management's outlook for organic sales growth of 5%-6% looks achievable on a balanced blend of volume and price increases, but we plan to trim our adjusted EPS estimate, before the earnings call, of $3.04 by a low-single-digit percentage to incorporate higher foreign currency headwinds. We don't plan any material changes to our $64 fair value estimate, and we view shares as fully valued.